Novo Nordisk has released the findings of its REDEFINE 2 trial, which compared the new weight loss drug, CagriSema, in adults with type 2 diabetes and overweight or obesity. CagriSema consists of two drugs, cagrilintide and semaglutide, aimed at suppressing hunger and weight loss.
The researchers set out to find out how over-time variation in insulin resistance (IR) may influence the development of cardiovascular disease (CVD). Researchers studied data from a large Chinese health survey and used two key markers to measure IR: the triglyceride-glucose (TyG) index and the TyG-BMI index (which combines TyG with body mass index).
A research study looked at the impact of a 1-week low-carbohydrate diet on increasing insulin sensitivity and vascular function in type 1 diabetes.
A recent study conducted by the Mailman School of Public Health at Columbia University has discovered that adults with diabetes who exercise according to guidelines can lower their risk of premature death regardless of the number of hours spent sitting per day. This is the first study to demonstrate that regular exercise can reverse the risks of sitting for long periods, particularly in individuals with diabetes. The results of this study were published in the journal Diabetes Care.
A recent study conducted by the Mailman School of Public Health at Columbia University has discovered that adults with diabetes who exercise according to guidelines can lower their risk of premature death regardless of the number of hours spent sitting per day. This is the first study to demonstrate that regular exercise can reverse the risks of sitting for long periods, particularly in individuals with diabetes. The results of this study were published in the journal Diabetes Care.
This study from the CORDIOPREV trial explored how small genetic molecules known as microRNAs (miRNAs) could assist doctors in selecting the most suitable diet for patients with both heart disease and Type 2 diabetes, potentially aiding in the reversal of their diabetes.